5-strategies-to-address-the-harms-of-market-driven-drug-development

Investment in novel therapies in the U.S. is frequently influenced by market opportunities rather than healthcare needs, exacerbating health inequalities and resulting in loss of life. Experts indicate that these suggestions might be beneficial.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This